Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Raquel Costa, Scott Teasdale, Sandra Abreu, Tânia Bastos, Michel Probst, Simon Rosenbaum, Philip B. Ward & Rui Corredeira. (2019) Dietary Intake, Adherence to Mediterranean Diet and Lifestyle-Related Factors in People with Schizophrenia. Issues in Mental Health Nursing 40:10, pages 851-860.
Read now
Read now
Daisy Ng-Mak & Krithika Rajagopalan. (2019) Examining quality of care for individuals treated for mental health using the HEDIS mental health quality measures. Current Medical Research and Opinion 35:1, pages 87-95.
Read now
Read now
William Montgomery, Tamas Treuer, Wenyu Ye, Hai Bo Xue, Sheng Hu Wu, Li Liu, Zbigniew Kadziola, Michael D Stensland & Haya Ascher-Svanum. (2014) Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?. Neuropsychiatric Disease and Treatment 10, pages 1287-1296.
Read now
Read now
Wenyu Ye, William Montgomery, Zbigniew Kadziola, Li Liu, Haibo Xue, Michael D Stensland & Tamas Treuer. (2014) Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China. Neuropsychiatric Disease and Treatment 10, pages 869-878.
Read now
Read now
Hai Bo Haber Xue, Li Liu, Hena Zhang, William Montgomery & Tamás Treuer. (2014) Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review. Neuropsychiatric Disease and Treatment 10, pages 841-864.
Read now
Read now
Joachim Cordes, Johanna Thünker, Gunnar Regenbrecht, Jürgen Zielasek, Christoph U. Correll, Christian Schmidt-Kraepelin, Christian Lange-Asschenfeldt, Marcus W. Agelink, Kai G. Kahl, Wolfgang Gaebel, Ansgar Klimke & Hans Hauner. (2014) Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial. The World Journal of Biological Psychiatry 15:3, pages 229-241.
Read now
Read now
Articles from other publishers (34)
Hiba Mutwalli, Johanna Louise Keeler, Sevgi Bektas, Namrata Dhopatkar, Janet Treasure & Hubertus Himmerich. (2023) Eating cognitions, emotions and behaviour under treatment with second generation antipsychotics: A systematic review and meta-analysis. Journal of Psychiatric Research 160, pages 137-162.
Crossref
Crossref
Angelique F. Ralph, Leah Brennan, Sue Byrne, Belinda Caldwell, Jo Farmer, Laura M. Hart, Gabriella A. Heruc, Sarah Maguire, Milan K. Piya, Julia Quin, Sarah K. Trobe, Andrew Wallis, AJ Williams-Tchen & Phillipa Hay. (2022) Management of eating disorders for people with higher weight: clinical practice guideline. Journal of Eating Disorders 10:1.
Crossref
Crossref
Nick Meader, Hollie Melton, Connor Evans, Kath Wright, David Shiers, Elena Ratschen, Sofia Dias, Ceri Dare, Gordon Johnston, Harminder Kaur, Michel Syrett, Christopher J Armitage, Rachel Churchill, Simon Gilbody & Peter Coventry. (2022) Multiple versus single risk behaviour interventions for people with severe mental illness: a network meta-analysis and qualitative synthesis. Health and Social Care Delivery Research 10:6, pages 1-186.
Crossref
Crossref
Anoop Sankaranarayanan, Karthika Johnson, Sanop J. Mammen, Helen E. Wilding, Deepali Vasani, Vijaya Murali, Deborah Mitchison, David J. Castle & Phillipa Hay. (2021) Disordered Eating among People with Schizophrenia Spectrum Disorders: A Systematic Review. Nutrients 13:11, pages 3820.
Crossref
Crossref
Wenjuan Zhang, Qimeng Sun, Baixin Chen, Maria Basta, Chongtao Xu & Yun Li. (2021) Insomnia symptoms are associated with metabolic syndrome in patients with severe psychiatric disorders. Sleep Medicine 83, pages 168-174.
Crossref
Crossref
Céline Dubath, Mehdi Gholam-Rezaee, Jennifer Sjaarda, Axel Levier, Nuria Saigi-Morgui, Aurélie Delacrétaz, Anaïs Glatard, Radoslaw Panczak, Christoph U. Correll, Alessandra Solida, Kerstin Jessica Plessen, Armin von Gunten, Zoltan Kutalik, Philippe Conus & Chin B. Eap. (2021) Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort. Translational Psychiatry 11:1.
Crossref
Crossref
Ambra Craba, Marianna Mazza, Giuseppe Marano, Lucio Rinaldi, Gabriele Sani & Luigi Janiri. (2021) Which comes first? New insights on comorbidity between eating disorders and bipolar disorders. Emerging Trends in Drugs, Addictions, and Health 1, pages 100023.
Crossref
Crossref
Nicolette Stogios, Emily Smith, Roshanak Asgariroozbehani, Laurie Hamel, Alexander Gdanski, Peter Selby, Sanjeev Sockalingam, Ariel Graff-Guerrero, Valerie Taylor, Sri Agarwal & Margaret Hahn. (2020) Exploring Patterns of Disturbed Eating in Psychosis: A Scoping Review. Nutrients 12:12, pages 3883.
Crossref
Crossref
J. Frayne, Y. Hauck, P. Sivakumar, T. Nguyen, H. Liira & V. A. Morgan. (2020) Nutritional status, food choices, barriers and facilitators to healthy nutrition in pregnant women with severe mental illness: a mixed methods approach. Journal of Human Nutrition and Dietetics 33:5, pages 698-707.
Crossref
Crossref
Scott B. Teasdale, Philip B. Ward, Katherine Samaras, Joseph Firth, Brendon Stubbs, Elise Tripodi & Tracy L. Burrows. (2019) Dietary intake of people with severe mental illness: systematic review and meta-analysis. The British Journal of Psychiatry 214:5, pages 251-259.
Crossref
Crossref
Kelly L. WuAmanda K. LorenzKelly J. ChristensenMolly A. FeelyElise C. CareyJacob J. Strand. (2019) Resurgence of Eating Disorders with Olanzapine. Journal of Palliative Medicine 22:2, pages 231-233.
Crossref
Crossref
Guillaume Fond. (2018) Le microbiote intestinal gouverne-t-il notre cerveau ?. Annales Médico-psychologiques, revue psychiatrique 176:8, pages 824-830.
Crossref
Crossref
Nick Meader. (2018) Promising evidence for nutrition interventions in people with serious mental illness. British Journal of Psychiatry 210:2, pages 94-95.
Crossref
Crossref
Scott B. Teasdale, Philip B. Ward, Simon Rosenbaum, Katherine Samaras & Brendon Stubbs. (2018) Solving a weighty problem: Systematic review and meta-analysis of nutrition interventions in severe mental illness. British Journal of Psychiatry 210:2, pages 110-118.
Crossref
Crossref
Louise Benarroch, Chantel Kowalchuk, Virginia Wilson, Celine Teo, Melanie Guenette, Araba Chintoh, Yasika Nesarajah, Valerie Taylor, Peter Selby, Paul Fletcher, Gary J. Remington & Margaret K. Hahn. (2016) Atypical antipsychotics and effects on feeding: from mice to men. Psychopharmacology 233:14, pages 2629-2653.
Crossref
Crossref
Scott B. Teasdale, Philip B. Ward, Simon Rosenbaum, Andrew Watkins, Jackie Curtis, Megan Kalucy & Katherine Samaras. (2016) A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis. British Journal of Nutrition 115:11, pages 1987-1993.
Crossref
Crossref
Guillaume Fond, Grégoire Chevalier, Gerard Eberl & Marion Leboyer. (2016) Le rôle potentiel du microbiote intestinal dans les troubles psychiatriques majeurs : mécanismes, données fondamentales, comorbidités gastro-intestinales et options thérapeutiques. La Presse Médicale 45:1, pages 7-19.
Crossref
Crossref
G. Fond, W. Boukouaci, G. Chevalier, A. Regnault, G. Eberl, N. Hamdani, F. Dickerson, A. Macgregor, L. Boyer, A. Dargel, J. Oliveira, R. Tamouza & M. Leboyer. (2015) The “psychomicrobiotic”: Targeting microbiota in major psychiatric disorders: A systematic review. Pathologie Biologie 63:1, pages 35-42.
Crossref
Crossref
Jean Lachaine, Catherine Beauchemin, Karine Mathurin, Dominique Gilbert & Maud Beillat. (2014) Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada. BMC Psychiatry 14:1.
Crossref
Crossref
Shengqiang Shu, Hao Liu, Min Wang, Dezhen Su, Lihua Yao & Gaohua Wang. (2014) Subchronic olanzapine treatment decreases the expression of pancreatic glucose transporter 2 in rat pancreatic β cells. Journal of Endocrinological Investigation 37:7, pages 667-673.
Crossref
Crossref
Maarten Bak, Annemarie Fransen, Jouke Janssen, Jim van Os & Marjan Drukker. (2014) Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis. PLoS ONE 9:4, pages e94112.
Crossref
Crossref
E. M. van der Zwaal, S. K. Janhunen, S. E. la Fleur & R. A. H. Adan. (2013) Modelling olanzapine-induced weight gain in rats. The International Journal of Neuropsychopharmacology 17:01, pages 169-186.
Crossref
Crossref
Núria Manzanares, Rosa Monseny, Laura Ortega, Itziar Montalvo, Joan Franch, Alfonso Gutiérrez-Zotes, Rebecca M. Reynolds, Brian R. Walker, Elisabet Vilella & Javier Labad. (2014) Unhealthy lifestyle in early psychoses: The role of life stress and the hypothalamic–pituitary–adrenal axis. Psychoneuroendocrinology 39, pages 1-10.
Crossref
Crossref
Hwang-Bin Lee, Bo-Hyun Yoon, Young-Joon Kwon, Young Sup Woo, Jung-Goo Lee, Moon-Doo Kim & Won-Myong Bahk. (2013) The Efficacy and Safety of Switching to Ziprasidone from Olanzapine in Patients with Bipolar I Disorder: An 8-Week, Multicenter, Open-Label Study. Clinical Drug Investigation 33:10, pages 743-753.
Crossref
Crossref
Salvatore Dipasquale, Carmine M. Pariante, Paola Dazzan, Eugenio Aguglia, Philip McGuire & Valeria Mondelli. (2013) The dietary pattern of patients with schizophrenia: A systematic review. Journal of Psychiatric Research 47:2, pages 197-207.
Crossref
Crossref
Robert C. Smith, Saumya Rachakonda, Saurabh Dwivedi & John M. Davis. (2012) Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients. Psychiatry Research 199:3, pages 159-163.
Crossref
Crossref
Daniel B Kurbanov, Paul J Currie, Donald C Simonson, David Borsook & Igor Elman. (2012) Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats. Journal of Psychopharmacology 26:9, pages 1244-1251.
Crossref
Crossref
Chao Deng, Jiamei Lian, Nagesh Pai & Xu-Feng Huang. (2012) Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model. Journal of Psychopharmacology 26:9, pages 1271-1279.
Crossref
Crossref
Kieran J. Davey, Siobhain M. O’Mahony, Harriet Schellekens, Orla O’Sullivan, John Bienenstock, Paul D. Cotter, Timothy G. Dinan & John F. Cryan. (2012) Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology 221:1, pages 155-169.
Crossref
Crossref
Elisabeth K. Degenhardt, Hassan H. Jamal, Susan Tormey & Michael Case. (2011) Early Weight Gain as a Predictor of Substantial Weight Gain With Olanzapine/Fluoxetine Combination. Journal of Clinical Psychopharmacology 31:3, pages 337-340.
Crossref
Crossref
Ruth Ohlsen & Fiona Gaughran. (2011) Schizophrenia: A major risk factor for cardiovascular disease. British Journal of Cardiac Nursing 6:5, pages 228-232.
Crossref
Crossref
Thomas L. Schwartz & Stephen M. Stahl. (2011) Treatment Strategies for Dosing the Second Generation Antipsychotics. CNS Neuroscience & Therapeutics 17:2, pages 110-117.
Crossref
Crossref
Michael Case, Tamas Treuer, Jamie Karagianis & Vicki Poole Hoffmann. (2010) The potential role of appetite in predicting weight changes during treatment with olanzapine. BMC Psychiatry 10:1.
Crossref
Crossref
J. Karagianis, J. Landry, V. P. Hoffmann, L. Grossman, L. De Haan, G. Maguire, R. Milev & S. Holt. (2010) An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study. International Journal of Clinical Practice 64:11, pages 1520-1529.
Crossref
Crossref